Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol --- United States, 1999--2002 and 2005--200.
Background: High levels of low-density lipoprotein cholesterol (LDL-C), a major risk factor for coronary heart disease (CHD), can be treated effectively. Methods: CDC analyzed data from 1999--2002 and 2005--2008 to examine the prevalence, treatment, and control of high LDL-C among U.S. adults aged >...
| Publicado en: | MMWR: Morbidity & Mortality Weekly Report Vol. 60; no. 4; pp. 109 - 115 |
|---|---|
| Formato: | research Journal Article |
| Publicado: |
Centers for Disease Control & Prevention (CDC)
2/4/2011
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104811829&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104811829 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01492195 MMW jtl: MMWR: Morbidity & Mortality Weekly Report issn: 01492195 maglogo: N pubinfo: dt: 2/4/2011 vid: 60 iid: 4 pid: 1493 pub: Centers for Disease Control & Prevention (CDC) place: Atlanta, Georgia artinfo: ui: 104811829 104811829 2010935912 NLM21293326 104811829 ppf: 109 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol --- United States, 1999--2002 and 2005--200. aug: sug: subj: Hypercholesterolemia Drug Therapy Hypercholesterolemia Epidemiology Lipoproteins, LDL Cholesterol Blood Adult Aged Female Health Services Accessibility Hispanic Americans Statistics and Numerical Data Human Insurance Coverage Male Middle Age Poverty Surveys United States Young Adult Adult: 19-44 years Aged: 65+ years Middle Aged: 45-64 years Female Male ab: Background: High levels of low-density lipoprotein cholesterol (LDL-C), a major risk factor for coronary heart disease (CHD), can be treated effectively. Methods: CDC analyzed data from 1999--2002 and 2005--2008 to examine the prevalence, treatment, and control of high LDL-C among U.S. adults aged >=20 years. Values were determined from blood specimens obtained from persons participating in the National Health and Nutrition Examination Survey (NHANES), a nationally representative cross-sectional, stratified, multistage probability sample survey of the U.S. civilian, noninstitutionalized population. The National Cholesterol Education Program Adult Treatment Panel-III guidelines set LDL-C goal levels of <100 mg/dL, <130 mg/dL, and <160 mg/dL for persons with high, intermediate, and low risk for developing CHD during the next 10 years, respectively. A person with high LDL-C was defined as either a person whose LDL-C levels were above the LDL-C goal levels or a person who reported currently taking cholesterol-lowering medication. Control of high LDL-C was defined as having a treated LDL-C value below the goal levels. Results: Based on data from the 2005--2008 NHANES, an estimated 71 million (33.5%) U.S. adults aged >=20 years had high LDL-C, but only 34 million (48.1%) were treated and 23 million (33.2%) had their LDL-C controlled. Among persons with uncontrolled LDL-C, 82.8% reported having some form of health insurance. The proportion of adults with high LDL-C who were treated increased from 28.4% to 48.1% between the 1999--2002 and 2005--2008 study periods. Among adults with high LDL-C, the prevalence of LDL-C control increased from 14.6% to 33.2% between the periods. The prevalence of LDL-C control was lowest among persons who reported receiving medical care less than twice in the previous year (11.7%), being uninsured (13.5%), being Mexican American (20.3%), or having income below the poverty level (21.9%). Conclusions: The prevalence of control of high LDL-C in the United States, although improving, remains low, especially among low-income adults and those with limited access to health care. Strengthening the use of preventive services through improvement in health-care access and quality of care is expected to help achieve better control of high LDL-C in the United States. Implications for Public Health Practice: To improve LDL-C control levels, a comprehensive approach that involves improved clinical care, as well as improved health-care access, sustainability, and affordability, is needed. A standardized system of patient care incorporating electronic health records, registries, and automated reminders for practitioners, focusing on achieving regular patient follow-up, has the potential to improve control of high LDL-C. Lower out-of-pocket costs and simplification of the drug regimen, as well as involvement of nurses, dietitians, health educators, pharmacists and other allied health-care professionals in direct patient care also could be used to improve patient adherence to prescribed regimens. pubtype: Academic Journal doctype: research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|